Royal Bank of Canada’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding PRAX
OAG
PA
BBA
VCM
DM
DCM
CAM
Royal Bank of Canada's PRAX Position: Q1 2026 in Review
Royal Bank of Canada increased its Praxis Precision Medicines (PRAX) stake by 22% in Q1 2026, buying an estimated $234K and bringing the position to 4,133 shares worth $1.33M. The position accounts for ﹤0.01% of the portfolio, ranked #3408.
Royal Bank of Canada first reported a position in PRAX in Q4 2020 and has held it in 19 quarters since. 289 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.
- Royal Bank of Canada held 4,133 shares of Praxis Precision Medicines worth $1.33M as of Q1 2026.
- Royal Bank of Canada bought 755 Praxis Precision Medicines shares in Q1 2026, an estimated $234K.
- Praxis Precision Medicines made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #3408 holding.
- Royal Bank of Canada first reported a position in Praxis Precision Medicines in Q4 2020 and has held it in 19 quarters since.
- 289 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.